Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (20)

2024

  1. Evolution of invasive pneumococcal disease by serotype 3 in adults: a Spanish three-decade retrospective study

    The Lancet Regional Health - Europe, Vol. 41

2023

  1. Enhancing SARS-CoV-2 Surveillance through Regular Genomic Sequencing in Spain: The RELECOV Network

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2022

  1. Genomic features of predominant non-PCV13 serotypes responsible for adult invasive pneumococcal disease in Spain

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 9, pp. 2389-2398

2021

  1. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  2. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

    Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761

2020

  1. Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 6, pp. 753-759

  2. The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

    Scientific Reports, Vol. 10, Núm. 1

2013

  1. Casos autodeclarados de síndrome gripal en trabajadores sanitarios españoles durante la pandemia de gripe A (H1N1) 2009

    Gaceta Sanitaria, Vol. 27, Núm. 2, pp. 167-170

  2. Epidemiological and clinical complexity of amoxicillin-clavulanate- resistant Escherichia coli

    Journal of Clinical Microbiology, Vol. 51, Núm. 7, pp. 2414-2417

  3. Viral infections of the central nervous system in Spain: A prospective study

    Journal of Medical Virology, Vol. 85, Núm. 3, pp. 554-562

2012

  1. Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli

    Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3576-3581

2011

  1. Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 5, pp. 997-1000

  2. Microbiological diagnosis of central nervous system infections

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 2, pp. 127-134

2009

  1. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain

    Emerging Infectious Diseases, Vol. 15, Núm. 6, pp. 905-911

2006

  1. Molecular epidemiology and variants of the multidrug-resistant Streptococcus pneumoniae Spain14-5 international clone among Spanish clinical isolates

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 4, pp. 654-660

2005

  1. Clinical isolates of the Spain14-5 clone of Streptococcus pneumoniae carry a recombinant rpoB gene [3]

    Antimicrobial Agents and Chemotherapy

2004

  1. Aislamiento de Mycobacterium lentiflavum sin valor clínico en 30 pacientes

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Spectrum of antibiotic resistance of the Spain14-5 Streptococcus pneumoniae clone over a 22 year period

    Journal of Antimicrobial Chemotherapy, Vol. 53, Núm. 4, pp. 620-625

2000

  1. Micobacterias ambientales en España: Aislamientos en el período 1976-1996

    Medicina Clinica, Vol. 115, Núm. 17, pp. 663-670

1988

  1. PENICILLIN-RESISTANT STRAINS OF NEISSERIA MENINGITIDIS IN SPAIN

    The Lancet